Tactile Systems Technology (NASDAQ:TCMD) Share Price Breaks Above 200 Day Moving Average After Analyst Downgrade

Tactile Systems Technology, Inc. (NASDAQ:TCMD) shares passed above its two hundred day moving average during trading on Wednesday after Wall Street Zen upgraded the stock from a buy rating to a strong-buy rating. The stock has a two hundred day moving average of $25.86 and traded as high as $28.71. Tactile Systems Technology shares last traded at $27.18, with a volume of 861,535 shares changing hands.

TCMD has been the subject of a number of other reports. Weiss Ratings upgraded shares of Tactile Systems Technology from a “hold (c)” rating to a “hold (c+)” rating in a research report on Tuesday, October 13th. BTIG Research reduced their price target on Tactile Systems Technology from $39.00 to $35.00 and set a “buy” rating on the stock in a research report on Monday, October 12th. Four analysts have rated the stock with a Buy rating and two have given a Hold rating to the company. According to data from MarketBeat, Tactile Systems Technology currently has an average rating of “Moderate Buy” and a consensus target price of $36.80.

Insider Activity at Tactile Systems Technology

In other news, CEO Sheri Dodd sold 10,978 shares of the company’s stock in a transaction dated Monday, August 10th. The shares were sold at an average price of $29.44, for a total value of $323,192.32. Following the completion of the sale, the chief executive officer directly owned 232,907 shares of the company’s stock, valued at approximately $6,856,782.08. This represents a 4.50% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders own 2.10% of the company’s stock.

Tactile Systems Technology News Summary

Here are the key news stories impacting Tactile Systems Technology this week:

• Positive Sentiment: TCMD reported Q3 adjusted earnings of $0.31 per share, above estimates of about $0.30. Lymphedema product revenue rose 13% year over year to $81.8 million, and technology improvements cut medical-record review times by about 50%. Tactile Systems: 3 Key Takeaways for Long-Term Investors
• Positive Sentiment: The stock moved above its 20-day moving average, which the article describes as a short-term bullish signal. The article also cites positive earnings-estimate revisions as a possible support for the shares. TCMD Just Overtook the 20-Day Moving Average
• Neutral Sentiment: Fiscal 2026 revenue guidance of $360 million to $366 million broadly brackets the $362.5 million consensus estimate. BTIG kept its Buy rating but cut its price target from $35 to $31, tempering the otherwise optimistic analyst outlook.
• Negative Sentiment: Quarterly revenue of $91.86 million slightly missed estimates, while earnings were down from $0.36 per share a year earlier. A report also highlighted a deepening AffloVest inventory issue, a potential offset to lymphedema growth. Tactile Medical earnings and inventory report

Institutional Investors Weigh In On Tactile Systems Technology

Several hedge funds have recently modified their holdings of the stock. Bank of New York Mellon Corp purchased a new position in Tactile Systems Technology in the 2nd quarter valued at $4,561,000. Empowered Funds LLC purchased a new position in Tactile Systems Technology during the 2nd quarter worth $3,607,000. BlackRock Inc. acquired a new stake in shares of Tactile Systems Technology in the 2nd quarter worth $56,733,000. Punch & Associates Investment Management Inc. acquired a new stake in shares of Tactile Systems Technology in the 2nd quarter worth $9,381,000. Finally, Deutsche Bank AG acquired a new stake in shares of Tactile Systems Technology in the 2nd quarter worth $5,145,000. 83.43% of the stock is owned by institutional investors and hedge funds.

Tactile Systems Technology Stock Up 9.7%

The company’s fifty day moving average price is $22.82 and its two-hundred day moving average price is $25.86. The firm has a market cap of $608.83 million, a PE ratio of 26.39 and a beta of 0.95.

Tactile Systems Technology (NASDAQ:TCMD) last released its earnings results on Monday, November 2nd. The company reported $0.31 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.28 by $0.03. Tactile Systems Technology had a return on equity of 10.73% and a net margin of 6.68%. The company had revenue of $91.86 million for the quarter, compared to analysts’ expectations of $91.99 million. As a group, analysts predict that Tactile Systems Technology, Inc. will post 1.10 earnings per share for the current year.

About Tactile Systems Technology

Tactile Systems Technology, doing business as Tactile Medical, develops and provides medical devices and services for people with chronic swelling and related conditions. The company focuses primarily on lymphedema and chronic venous insufficiency, conditions that can cause persistent fluid buildup in the limbs and trunk.

Its principal products include advanced pneumatic compression devices, such as the Flexitouch Plus system for the treatment of lymphedema and the Entre Plus system for home treatment of lymphedema and chronic venous insufficiency.